Edge Rewrite
everything Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a25418456dc8c235

Jump to content

Cost Plus Drugs

Add links
From Wikipedia, the free encyclopedia

Cost Plus Drugs
TypePrivate
IndustryPharmaceuticals
FoundersAlex Oshmyansky and Mark Cuban
Headquarters
Dallas, Texas
,
US
Key people
Alex Oshmyansky and Mark Cuban
Websitecostplusdrugs.com Edit this at Wikidata

Mark Cuban Cost Plus Drug Company (MCCPDC), doing business as Cost Plus Drugs, is an American public benefit corporation, founded in 2022[1] with its main headquarters located in Dallas, Texas. The company is focused on the pharmacy distribution of drugs with a stated goal to lower the prices for generic drugs by removing middlemen, such as pharmacy benefit managers, and by moving to a cost-plus pricing strategy.[2]

Origins and concept

[edit]

Cost Plus Drugs was launched in January 2022.[3] It was co-founded by radiologist Alex Oshmyansky and billionaire Mark Cuban. According to Cuban, in 2018, Oshmyansky contacted Cuban with an email titled "cold pitch" in which he asked Cuban to invest in a pharmacy he envisioned to manufacture generic drugs and skip the middleman wholesalers.[4] The company has said that the intermediary layer of the pharmacy benefit managers is typically responsible for the heavy markup that drugs see between the manufacturers and the customers.[5] The company originally used Truepill Pharmacy to fill prescriptions, but later transitioned to HealthDyne.[6][7] Prices are direct to consumer, without any need or role for insurance.

Operations and scale

[edit]

Oshmyansky is the founder and CEO.[4][2] The manufacturing facility, constructed in the Deep Ellum area of Dallas, Texas, was completed in 2023 and features a 22,000 square foot sterile facility that features top-of-the-line aseptic robotic filling lines to ensure that both injectable medication and drugs listed on the FDA Drug Shortages list meet the demand of the population.[2]

While originally built as a direct-to-patient pharmacy, MCCPDC built its own "Marketplace" in 2024. This "Marketplace" essentially serves a wholesale business that sells medications directly to surgery centers, outpatient clinics, hospitals, retail pharmacies, and long-term care facilities. While this segment of the MCCPDC stocks many medications, the focus remains on being able to provide injectables which are commonly seen in shortages.

Franklin, Tennessee based Community Health System (CHS) was the first health system to partner with MCCPDC's "Marketplace." In this business partnership MCCPDC shipped multiple packages of epinephrine and norepinephrine to nine CHS hospitals. After seeing success with this business model, CHS expanded its' relationship with the organization by adding an additional 62 hospitals -- soon after, Louisville, KY-based ScionHealth joined as the second inaugural partner in May 2024, reaching 94 hospitals.

Furthermore, in March 2026, MCCPDC in collaboration with GraphiteRx officially integrates its pricing inside already-existing hospital procurement workflows, allowing in-house pharmacists to see a side-by-side comparison of MCCPDC prices compared to traditional wholesalers.[8]

As of June 2022, the company had a selection of over 100 generic drugs,[9] and by March 2023, over 350 drugs were available.[10] In December 2023, the company had over 2200 drugs available. As of 2026, The drugs are sold for a price equivalent to the company's cost plus 15% markup, a $5 pharmacy service fee, and a $5.25 shipping fee.[5][11][7] The company ships to all 50 US states.[7]

See also

[edit]

References

[edit]
  1. ↑ "Everyone deserves safe and affordable medications". Mark Cuban Cost Plus Drug Company. Retrieved June 19, 2022.
  2. 1 2 3 "Mission of Mark Cuban Cost Plus Drugs". Mark Cuban Cost Plus Drug Company. Retrieved October 26, 2024.
  3. ↑ Hernandez, Joe (January 24, 2022). "Billionaire Mark Cuban launches online pharmacy aimed at lowering generic drug prices". NPR. Retrieved June 19, 2022.
  4. 1 2 Cesaric, Corin (April 14, 2022). "How Mark Cuban's online pharmacy plans to make medications affordable". NBC Chicago. Retrieved February 1, 2023.
  5. 1 2 Foster, Tom (May 2022). "Mark Cuban's audacious cure for high-priced drugs". Inc.com.
  6. ↑ Twenter, Paige (June 6, 2023). "Mark Cuban's drug company partners with 2 mail-order pharmacies". Becker's Hospital Review. Retrieved January 28, 2026.
  7. 1 2 3 "Questions Frequently Asked and Answers". Mark Cuban Cost Plus Drug Company. Retrieved January 28, 2026.
  8. ↑ Emerson, Jakob (April 30, 2026). "Mark Cuban's healthcare playbook, explained - Becker's Hospital Review | Healthcare News & Analysis". Becker's Hospital Review | Healthcare News & Analysis. Archived from the original on May 20, 2026. Retrieved June 3, 2026.
  9. ↑ Nolan, Emma (June 7, 2022). "New Mark Cuban company slashes high drug prices: "Life changing"". Newsweek. Retrieved June 19, 2022.
  10. ↑ Dahl, William. "Mark Cuban Aims To Disrupt A $365 Billion Industry – With The Only Startup That Bears His Name". Benzinga. Retrieved December 30, 2024.
  11. ↑ Murphy, Heather Tal (January 28, 2023). "The Truth About Amazon's Really Cheap Generic Drugs". Slate. ISSN 1091-2339. Retrieved December 30, 2024.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Cost_Plus_Drugs&oldid=1367305871"